Medulloblastoma in a child with fragile X syndrome

George A Alexiou1, George Siozos, Kalliopi Stefanaki

  • 1Department of Neurosurgery, Children's Hospital Agia Sofia, Athens, Greece. alexiougrg@yahoo.gr

Neuropediatrics
|May 19, 2012
PubMed

Insights

Fragile X syndrome, a common cause of intellectual disability, is linked to lower cancer rates. This report details the first known case of medulloblastoma in a child with Fragile X syndrome.

Area of Science:

  • Neuroscience
  • Oncology
  • Genetics

Background:

  • Fragile X syndrome (FXS) is the leading inherited cause of intellectual disability.
  • FXS is paradoxically associated with a reduced incidence of various cancers.
  • The interplay between FXS genetics and cancer risk remains incompletely understood.

Observation:

  • An 11-year-old boy with diagnosed FXS presented with neurological symptoms: gait imbalance, headache, and vomiting.
  • Radiological imaging identified a tumor in the posterior fossa.
  • Surgical resection confirmed the tumor as medulloblastoma (MB).

Findings:

  • This case represents the first documented instance of medulloblastoma (MB) occurring in a pediatric patient with Fragile X syndrome.
  • The co-occurrence challenges the previously observed trend of decreased cancer incidence in FXS.

Implications:

  • This unique case prompts further investigation into potential biological mechanisms linking FXS and specific tumor types like MB.
  • Understanding this association may offer new insights into cancer development and prevention strategies for individuals with FXS.
  • Further research is warranted to explore the oncological implications and potential genetic or molecular pathways involved.